Bicyclic GPR119 modulators

A compound of Formula (II):

• or pharmaceutically acceptable salt thereof;
• wherein,
• is a double bond;
• R2 is selected from the group consisting of hydrogen, alkyl, and halo;
• R3 is selected from the group consisting of —S(O)pRa, —C(O)ORa, —(CH2)qC(O)NRaRb, —(CH2)qN(Ra)C(O)Rb, —N(Ra)C(O)ORb, —N(Ra)C(O)NRaRb, —S(O)2NRaRb, —N(Ra)S(O)2Rb, —CN, alkoxy, hydroxyalkyl, heterocyclyl and heteroaryl;
• Ra and Rb are each independently selected from the group consisting of hydrogen, alkyl, haloalkyl, hydroxy, alkenyl, alkynyl, cycloalkyl, hydroxyalkyl, alkoxyalkyl, aryl, heteroaryl, arylalkyl, and heterocyclyl;
• or Ra and Rb may join together with the nitrogen atom to which they are attached to form a heterocyclic ring;
• Z is selected from the group consisting of alkyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, cycloalkylalkyl, heterocyclylalkyl, heteroarylalkyl, arylalkyl, haloalkyl, hydroxyalkyl, —(CH2)qC(O)ORa, —(CH2)qC(O)Ra, —C(O)(CH2)qNRaRb, —(CH2)qC(O)NRaRb, —S(O)2Ra, —S(O)2NRaRb, —C(O)CR,RdRe and —(CH2)qCRcRdRe;
• RcRd and Re are each independently selected from the group consisting of hydrogen, halogen, hydroxyl, alkyl, haloalkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, arylalkyl, and heterocyclyl;
• or Rc and Rd may join together with the carbon atom to which they are attached to form a 3 to 7 membered carbocyclic or heterocyclic ring;
• R5, R6, R7, R8 are hydrogen;
• or
• any two of R5, R6, R7, R8 and Z may join together to form a cycloalkyl or heterocyclyl ring;
• X is selected from the group consisting of —(CR10R11)qO(CR10R11)t—, —(CR10R11)qS(O)p(CR10R11)t— and —(CR10R11)qNR9(CR10R11)t—;
• R9 is hydrogen or alkyl;
• R10 and R11 are hydrogen;
• ‘m’, ‘n’ and ‘p’ are each independently selected from 0, 1 or 2;
• ‘q’ is an integer ranging from 0 to 4, both inclusive;
• ‘t’ is an integer ranging from 0 to 4, both inclusive;
• and
• wherein, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, heteroaryl, heterocyclyl, heterocyclic ring, alkoxy, hydroxyalkyl, haloalkyl, arylalkyl, heterocyclylalkyl, heteroarylalkyl and carbocyclic ring wherever they occur may optionally be substituted with one or more substituents independently selected from hydroxy, halo, cyano, nitro, oxo (═O), thio (═S), alkyl, haloalkyl, alkenyl, alkynyl, aryl, arylalkyl, cycloalkyl, cycloalkylalkyl, cycloalkenyl, heteroaryl, heterocyclic ring, heterocyclylalkyl, heteroarylalkyl, —C(O)ORx, —C(O)Rx, —C(S)Rx, —C(O)NRxRy, —NRxC(O)NRyRz, —N(Rx)S(O)Ry, —N(Rx)S(O)2Ry, —NRxRy, —NRxC(O)Ry, —NRxC(S)Ry, —NRxC(S)NRyRz, —S(O)NRxRy, —S(O)2NRxRy, —ORx, —OC(O)Rx, —OC(O)NRxRy, —RxC(O)ORy, —RxC(O)NRyRz, —RxC(O)Ry, —SRX, —S(O)Rx, and —S(O)2Rx;
• wherein each occurrence of Rx, Ry and Rz are independently selected from hydrogen, alkyl, haloalkyl, alkenyl, alkynyl, aryl, arylalkyl, cycloalkyl, cycloalkenyl, heteroaryl, heterocyclic ring, heterocyclylalkyl ring and heteroarylalkyl.